With rates of ECMO utilization on the rise, prevention of nosocomial infections is of paramount importance. Candida auris, an emerging highly pathogenic multidrug resistant fungus, is of particular concern as it is associated with persistent colonization of environmental surfaces, inability to be recognized by many diagnostic platforms, inconsistent laboratory susceptibility results, and high mortality rates. We describe a case of C. auris in a VV-ECMO patient successfully managed with a combination of anidulafungin, amphotericin B, and flucytosine.
BizzarroMJConradSAKaufmanDA, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med2011; 12(3): 277–281.
2.
CavayasYAYusuffHPorterR. Fungal infections in adult patients on extracorporeal life support. Crit Care2018; 22: 1–7.
3.
Osei SekyereJ. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen2018; 7: e00578.
PappasPGKauffmanCAAndesDR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis2016; 62: e1–e50.
6.
AguilarGFerriolsRCarbonellJA, et al. Pharmacokinetics of anidulafungin during venovenous extracorporeal membrane oxygenation. Crit Care2016; 20: 1–2.
7.
RexJHBennettJESugarAM, et al. Intravascular catheter exchange and duration of Candidemia. Clin Infect Dis1995; 21: 994–996.
8.
MDHHS. Candida auris in Michigan. Michigan Clinical Providers Brief, 2023.
9.
ZhaoYSeelhammerTGBarretoEF, et al. Altered pharmacokinetics and dosing of liposomal amphotericin b and isavuconazole during extracorporeal membrane oxygenation. Pharmacotherapy2020; 40: 89–95.
10.
FoulquierJBBerneauPFrérouA, et al. Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation. Med Mal Infect2019; 49: 69–71.
11.
FolkABaltaCHermanH, et al. Flucytosine and amphotericin B coadministration induces dose-related renal injury. Dose-Response. 2017; 15(2): 155932581770346.
12.
FotiLVillaGRomagnoliSRicciZ. Acute kidney injury and extracorporeal membrane oxygenation: review on multiple organ support options. Int J Nephrol Renovasc Dis2021; 14: 321–329.
13.
NettJEAndesDR. Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin2016; 30(1): 51–83.
